Healios AG is a MedTech company aiming to develop and validate digital biomarkers
Healios is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies. With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders. These novel biomarkers will establish a new standard for both pharmacological research and clinical practice.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 30, 2022 | Seed | — | 2 | — | — | Detail |
Dec 21, 2021 | Angel | Fr1.10M | — | — | — | Detail |
Aug 4, 2020 | Grant | $174.68K | — | — | — | Detail |
Jul 6, 2020 | Convertable Note | Fr1.10M | — | — | — | Detail |
Oct 10, 2019 | Grant | Fr55K | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lichtsteiner Foundation | — | Seed |
Zühlke Ventures AG | — | Seed |